Chevy Chase Trust
DGX icon

Chevy Chase Trust’s Quest Diagnostics DGX Stock Holding History

Chevy Chase Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.1M Sell
80,868
-1,029
-1% -$202K 0.04% 311
2026
Q1 		$16.1M Sell
81,897
-3,650
-4% -$709K 0.05% 307
2025
Q4 		$14.8M Sell
85,547
-1,545
-2% -$281K 0.04% 323
2025
Q3 		$16.6M Sell
87,092
-5,651
-6% -$1M 0.05% 300
2025
Q2 		$16.7M Sell
92,743
-19,387
-17% -$3.37M 0.05% 293
2025
Q1 		$19M Buy
112,130
+10,342
+10% +$1.7M 0.06% 264
2024
Q4 		$15.4M Buy
101,788
+11,821
+13% +$1.84M 0.05% 316
2024
Q3 		$14M Buy
89,967
+11,496
+15% +$1.72M 0.04% 345
2024
Q2 		$10.7M Sell
78,471
-1,661
-2% -$227K 0.03% 373
2024
Q1 		$10.7M Sell
80,132
-1,432
-2% -$186K 0.03% 389
2023
Q4 		$11.2M Sell
81,564
-1,004
-1% -$132K 0.04% 359
2023
Q3 		$10.1M Sell
82,568
-1,534
-2% -$204K 0.04% 358
2023
Q2 		$11.8M Sell
84,102
-162
-0.2% -$22.3K 0.04% 343
2023
Q1 		$11.9M Sell
84,264
-1,426
-2% -$204K 0.05% 339
2022
Q4 		$13.4M Sell
85,690
-13,038
-13% -$1.87M 0.06% 309
2022
Q3 		$12.1M Buy
98,728
+786
+0.8% +$104K 0.05% 327
2022
Q2 		$13M Sell
97,942
-928
-0.9% -$126K 0.05% 319
2022
Q1 		$13.5M Buy
98,870
+3,650
+4% +$509K 0.05% 342
2021
Q4 		$16.5M Sell
95,220
-1,829
-2% -$278K 0.05% 311
2021
Q3 		$14.1M Sell
97,049
-8,198
-8% -$1.2M 0.05% 329
2021
Q2 		$13.9M Sell
105,247
-6,760
-6% -$885K 0.05% 344
2021
Q1 		$14.4M Sell
112,007
-12,053
-10% -$1.49M 0.05% 332
2020
Q4 		$14.7M Sell
124,060
-9,633
-7% -$1.17M 0.05% 314
2020
Q3 		$15.3M Sell
133,693
-18,986
-12% -$2.24M 0.06% 286
2020
Q2 		$17.4M Buy
152,679
+1,776
+1% +$188K 0.07% 258
2020
Q1 		$12.1M Buy
150,903
+1,079
+0.7% +$112K 0.06% 298
2019
Q4 		$16M Buy
149,824
+6,199
+4% +$646K 0.06% 316
2019
Q3 		$15.4M Buy
143,625
+31,438
+28% +$3.23M 0.06% 305
2019
Q2 		$11.4M Buy
112,187
+209
+0.2% +$20.1K 0.05% 370
2019
Q1 		$10.8M Buy
111,978
+27
+0% +$2.34K 0.04% 392
2018
Q4 		$9.32M Sell
111,951
-255
-0.2% -$23.9K 0.05% 384
2018
Q3 		$12.1M Sell
112,206
-2,058
-2% -$226K 0.05% 367
2018
Q2 		$12.6M Sell
114,264
-651
-0.6% -$67.8K 0.05% 354
2018
Q1 		$11.5M Sell
114,915
-3,355
-3% -$344K 0.05% 384
2017
Q4 		$11.6M Sell
118,270
-1,236
-1% -$117K 0.05% 377
2017
Q3 		$11.2M Buy
119,506
+1,141
+1% +$121K 0.05% 374
2017
Q2 		$13.2M Sell
118,365
-458
-0.4% -$48.4K 0.06% 318
2017
Q1 		$11.7M Buy
118,823
+2,668
+2% +$254K 0.06% 343
2016
Q4 		$10.7M Sell
116,155
-160
-0.1% -$13.8K 0.06% 348
2016
Q3 		$9.84M Sell
116,315
-4,867
-4% -$409K 0.05% 364
2016
Q2 		$9.87M Buy
121,182
+386
+0.3% +$29.4K 0.06% 360
2016
Q1 		$8.63M Buy
120,796
+4,849
+4% +$325K 0.05% 388
2015
Q4 		$8.25M Buy
115,947
+607
+0.5% +$40.8K 0.05% 384
2015
Q3 		$7.09M Buy
115,340
+1,698
+1% +$119K 0.04% 410
2015
Q2 		$8.24M Buy
113,642
+673
+0.6% +$49.7K 0.05% 387
2015
Q1 		$8.68M Buy
112,969
+3,597
+3% +$258K 0.05% 382
2014
Q4 		$7.33M Sell
109,372
-905
-0.8% -$57.1K 0.05% 409
2014
Q3 		$6.69M Buy
110,277
+6,673
+6% +$411K 0.04% 426
2014
Q2 		$6.08M Buy
103,604
+829
+0.8% +$48.5K 0.04% 432
2014
Q1 		$5.95M Sell
102,775
-4,462
-4% -$239K 0.04% 423
2013
Q4 		$5.74M Sell
107,237
-333
-0.3% -$19.8K 0.04% 430
2013
Q3 		$6.65M Sell
107,570
-2,618
-2% -$157K 0.05% 374
2013
Q2 		$6.68M Buy
+110,188
New +$6.56M 0.06% 360

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Chevy Chase Trust's DGX Position: Q2 2026 in Review

Chevy Chase Trust reduced its Quest Diagnostics (DGX) stake by 1.3% in Q2 2026, selling an estimated $202K and leaving 80,868 shares worth $17.1M. The position accounts for 0.04% of the portfolio, ranked #311.

Chevy Chase Trust first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $19M in Q1 2025. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Chevy Chase Trust held 80,868 shares of Quest Diagnostics worth $17.1M as of Q2 2026.
  • Chevy Chase Trust sold 1,029 Quest Diagnostics shares in Q2 2026, an estimated $202K.
  • Quest Diagnostics made up 0.04% of Chevy Chase Trust's portfolio in Q2 2026, its #311 holding.
  • Chevy Chase Trust first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Chevy Chase Trust's Quest Diagnostics position peaked at $19M in Q1 2025.
  • 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.